Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Explore common reasons budgets fail and practical fixes you can apply now to improve accuracy, discipline, and long-term results.
20,131 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Palantir's quarterly results spotlight more than top-line growth. The real signal is how much existing customers are ...
Aster broadens its partnership with WLFI to introduce USD1-denominated perpetual contracts and new incentives, design...
Meta Platforms paused the public rollout of its Avocado AI model to focus on quality, while expanding its Hyperion da...
Carvana stock has faced a rough start to 2026, with the headline move being a sizable drop. This guide breaks down wh...
Your phone quietly tracks what you do online—and more. This article unpacks how data is collected, why it matters for...
Realty Income just announced a $1 billion joint venture with Apollo, expanding its real estate platform and preservin...
When a single security gap triggers a major depeg, everyday investors feel the impact first. This article unpacks res...
Fresh demand signals and disciplined supply dynamics are setting up Micron stock for potential upside. This guide bre...
Bitcoin headlines often swing between hype and fear. This article explores a cathie wood invest just approach to calm...
A high-profile musician argues that wealth isn’t a character flaw. This piece translates that stance into practical p...
When top executives trim their holdings, investors pay attention. This article breaks down what a well timed trim mea...